Form 8-K - Current report:
SEC Accession No. 0001437749-25-008047
Filing Date
2025-03-17
Accepted
2025-03-17 17:26:56
Documents
14
Period of Report
2025-03-11
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K krbp20250317_8k.htm   iXBRL 8-K 27326
  Complete submission text file 0001437749-25-008047.txt   166187

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA krbp-20250311.xsd EX-101.SCH 3579
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE krbp-20250311_def.xml EX-101.DEF 11436
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE krbp-20250311_lab.xml EX-101.LAB 15336
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE krbp-20250311_pre.xml EX-101.PRE 11596
16 EXTRACTED XBRL INSTANCE DOCUMENT krbp20250317_8k_htm.xml XML 2862
Mailing Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054
Business Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054 832-968-4888
Kiromic Biopharma, Inc. (Filer) CIK: 0001792581 (see all company filings)

EIN.: 464762913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39619 | Film No.: 25745727
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)